Speak directly to the analyst to clarify any post sales queries you may have.
The adult antipyretic market is evolving rapidly as innovative therapies, advanced formulations, and digital tools reshape fever management across health systems. Senior decision-makers are navigating a landscape characterized by shifting patient expectations, new regulatory frameworks, and the increasing integration of technology.
Market Snapshot: Adult Antipyretic Market Overview
Driven by the critical role of fever management in both primary care and hospital environments, the global adult antipyretic market is experiencing transformation through advancements in formulation chemistry and digital health integration. Acetaminophen retains its prominence due to its safety, while ibuprofen, aspirin, and naproxen remain essential for targeted patient needs. Emerging digital platforms and innovative delivery formats are supporting more effective patient care and streamlined clinical workflows. Growth is fueled by expanding demand, technology adoption, and a diverse mix of established and emerging market players, with a variety of commercial strategies adopted regionally.
Scope & Segmentation
- Active Ingredients: Acetaminophen, Aspirin, Ibuprofen, Naproxen
- Formulations: Suspension, Syrup, Suppository, Granule, Sachet, Tablet
- Distribution Channels: Hospital, Online Pharmacy, Hospital Pharmacy, Retail Pharmacy
- End Users: Clinics, Homecare, Hospitals
- Geographies: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Technologies: Lipid-based carriers, controlled-release matrices, digital health platforms, telemedicine, predictive algorithms, wearable sensors
- Leading Companies: Johnson & Johnson Services, Inc., Haleon plc, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Perrigo Company plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd, Viatris Inc, Dr. Reddy’s Laboratories Ltd
Key Takeaways for Senior Decision-Makers
- Molecular innovation and digital health platforms boost adherence and allow more precise, patient-centered antipyretic interventions.
- Segment-specific dosage forms, such as granules, suspensions, suppositories, and sachets, are aiding tailored treatment and supporting diverse patient cohorts in clinical and homecare settings.
- Distribution strategies are multi-faceted, combining hospital supply networks, robust online and retail pharmacy channels, and omnichannel digital ordering for broader reach.
- Regional approaches differ: North America emphasizes digital engagement and new formulations, while Europe and emerging markets balance branded and generic adoption to optimize for regulatory and cost dynamics.
- Collaborations between biotech firms and established pharmaceutical brands leverage real-world data and analytics, enabling rapid product development and regulatory submission.
Tariff Impact on Supply Chains and Pricing
The 2025 United States tariff on pharmaceutical imports significantly changed adult antipyretic supply chains, raising raw material costs and prompting diverse sourcing strategies. Manufacturers responded by renegotiating contracts, consolidating purchasing, and adopting tiered pricing for large healthcare networks. Proactive industry responses included manufacturing footprint diversification and supply chain localization to reduce exposure to tariff-related volatility, ultimately maintaining patient access and minimizing disruption to essential fever management products.
Methodology & Data Sources
This research employs primary data from stakeholder interviews and site visits in pharmaceutical manufacturing and healthcare settings, combined with secondary sources such as peer-reviewed literature and corporate reports. Rigorous statistical validation and consultations with pharmacologists and health economists provide a clear, reliable foundation for every market insight.
Why This Report Matters
- Helps industry leaders identify and evaluate growth opportunities through precise segmentation and actionable market entry strategies.
- Enables optimization of distribution, supply chain resilience, and patient engagement via evidence-driven recommendations that leverage advanced technologies.
- Provides clarity on regional differences and regulatory impacts, supporting informed decision-making for multinational operations.
Conclusion
The adult antipyretic therapeutics market is advancing through innovative formulations, digital integration, and resilient global supply chains. Industry stakeholders who prioritize collaborative innovation and supply chain agility will be best equipped for future growth and sustained impact.
This product will be delivered within 1-3 business days.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
5.2. Growing consumer preference for paracetamol based antipyretics enriched with natural extracts and wellness supplements for holistic fever relief
5.3. Impact of digital health monitoring devices and wearables on real time fever management influencing adult antipyretic consumption patterns
5.4. Expansion of fast dissolving oral antipyretic tablets offering rapid onset of action and enhanced convenience for adult patients with acute fever symptoms
5.5. Integration of personalized dosing recommendations through smartphone applications to optimize adult antipyretic treatment safety and effectiveness
5.6. Shifts in regulatory policies promoting expanded generic antipyretic approvals and their implications for pricing competition and market share dynamics
5.7. Increasing reliance on telemedicine consultations driving online adult antipyretic sales and reshaping traditional retail distribution channels
6.2. PESTLE Analysis
8.2. Acetaminophen
8.3. Aspirin
8.4. Ibuprofen
8.5. Naproxen
9.2. Liquid
9.2.1. Suspension
9.2.2. Syrup
9.3. Semi Solid
9.3.1. Suppository
9.4. Solid
9.4.1. Granule
9.4.2. Sachet
9.4.3. Tablet
10.2. Hospital
10.3. Online Pharmacy
10.4. Pharmacy
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
11.2. Clinics
11.3. Homecare
11.4. Hospitals
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson Services, Inc.
15.3.2. Haleon plc
15.3.3. Sanofi S.A.
15.3.4. Bayer AG
15.3.5. Reckitt Benckiser Group plc
15.3.6. Perrigo Company plc
15.3.7. Abbott Laboratories
15.3.8. Teva Pharmaceutical Industries Ltd
15.3.9. Viatris Inc
15.3.10. Dr. Reddy’s Laboratories Ltd
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
FIGURE 2. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ADULT ANTIPYRETICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ADULT ANTIPYRETICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ADULT ANTIPYRETICS MARKET: RESEARCHAI
FIGURE 24. ADULT ANTIPYRETICS MARKET: RESEARCHSTATISTICS
FIGURE 25. ADULT ANTIPYRETICS MARKET: RESEARCHCONTACTS
FIGURE 26. ADULT ANTIPYRETICS MARKET: RESEARCHARTICLES
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ASPIRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY NAPROXEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SUPPOSITORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SUPPOSITORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY GRANULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SACHET, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SACHET, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ADULT ANTIPYRETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ADULT ANTIPYRETICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 104. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 105. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 108. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 109. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 110. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 111. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 112. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 113. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 250. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 251. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 254. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 255. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 256. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 257. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 258. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 259. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 330. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 331. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 332. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 333. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 334. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 335. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 336. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 337. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 338. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 339. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 342. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 343. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. DENMARK ADULT ANTIPYRETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS ADULT ANTIPYRETICS MARKET SIZE, BY S
Samples
LOADING...
Companies Mentioned
The companies profiled in this Adult Antipyretics market report include:- Johnson & Johnson Services, Inc.
- Haleon plc
- Sanofi S.A.
- Bayer AG
- Reckitt Benckiser Group plc
- Perrigo Company plc
- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd
- Viatris Inc
- Dr. Reddy’s Laboratories Ltd